COMMUNIQUÉS West-GlobeNewswire

Diaxonhit : Nouvelle composition du conseil de surveillance
19/06/2017
Nouvelle composition du conseil de surveillance de DIAXONHIT Jean-Pierre HERMET est nommé président du conseil de surveillance Patrick de ROQUEMAUREL est nommé membre du conseil de surveillance Démissions de Laurent [...]
Sandoz receives approval in Europe for Rixathon® (biosimilar rituximab) to treat blood cancers and immunological diseases
19/06/2017
European Commission approves Sandoz Rixathon ® to treat blood cancers and immunological diseases. Approval expected to broa den patient access to biologics and enable budget-constrained healthcare systems to reallocate [...]
MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test
19/06/2017
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, June 19, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a scientific agreement with [...]
MDxHealth et l'Université de technologie du Queensland collaborent sur un test de biopsie liquide pour le dépistage de cancer buccal
19/06/2017
COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 AM CEST - Le 19 juin 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui qu'il a signé un [...]
Medtronic Exclusive Reactive ATP(TM) Therapy Slows Progression of Atrial Fibrillation in Real-World Patient Population
18/06/2017
Data Presented as Late Breaking Clinical Trial at EUROPACE 2017 DUBLIN and VIENNA - June 18, 2017 - Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc (NYSE: [...]
DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress
17/06/2017
Press Release Montrouge, France, June 17, 2017 DBV Technologies Highlights Poster Presentations on EPIT ® at the 2017 EAACI Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]
DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT®) au Congrès de l'EAACI 2017
17/06/2017
Communiqué de Presse Montrouge, France, 17 juin 2017, 8h30 CEST DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT ® ) au Congrès de l'EAACI 2017 DBV Technologies (Euronext : DBV - ISIN : [...]
Novartis International AG: New patient survey highlights need for more action to help severe asthma patients gain control of their disease
17/06/2017
Large-scale European patient survey found that 94% of severe allergic asthma patients were unable to fully control their disease These new data underscore the disconnect between self-perceived control and clinical [...]
GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017
16/06/2017
GENFIT : resultats de l'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017 - Approbation du changement du mode d'administration de la Société - Nomination du Président-Directeur Général et des Comités du [...]
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017
16/06/2017
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017 - Approval of the change in mode of administration and management of the Company - Nomination of the Chairman and CEO and the [...]
Diaxonhit : Assemblée générale ordinaire et extraordinaire annuelle
16/06/2017
Assemblée générale ordinaire et extraordinaire annuelle de Diaxonhit Les actionnaires ont adopté toutes les résolutions à titre ordinaire et à titre extraordinaire agréées par le directoire Paris, France - 16 juin 2017 [...]
FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update
16/06/2017
Bagsværd, Denmark, 16 June 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has published the briefing documents ahead of the Advisory Committee meeting to discuss the supplemental New [...]
Kymab Group Ltd: Kymab appoints Dr Martin Nicklasson as Non-Executive Chair
16/06/2017
Kymab appoints Dr Martin Nicklasson as Non-Executive Chair Cambridge, UK, 16 June 2017 - Kymab Group Limited ("Kymab"), a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Martin [...]
Bavarian Nordic Announces Notification of Request for Proposal for Freeze-Dried IMVAMUNE
16/06/2017
Sole source request will allow transition toward long-term stockpiling of Bavarian Nordic's smallpox vaccine COPENHAGEN, Denmark, June 16, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced notification [...]
Helsinn Investment Fund leads the financial round in GreenBone
16/06/2017
Helsinn Investment Fund leads the financial round in GreenBone New fund backed by the Helsinn Group, focused on supporting early stage opportunities in areas of high unmet patient need Euro 2 million investment in [...]
RECORDATI LICENSES AN INNOVATIVE TREATMENT FOR NEUROTROPHIC KERATITIS
16/06/2017
Milan, 16 June, 2017 - Recordati announced the signing of an exclusive license agreement with MimeTech, an Italian development stage company founded by scientists from the University in Florence, for the development and [...]
Annual General Meeting of Active Biotech AB
16/06/2017
PRESS RELEASE The Annual General Meeting of Active Biotech was held on June 15, 2017. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The board members and the [...]
Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study
16/06/2017
COPENHAGEN, Denmark, June 16, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today provided updated guidance for the current anticipated timing of interim and final results from its ongoing PROSPECT study, a placebo [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
16/06/2017
REGULATED INFORMATION GHENT, Belgium, 16 June 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Pages